Hospira to Present at Upcoming Investor Conferences
LAKE FOREST, Ill., April 22, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at three upcoming conferences:
- Bank of America Merrill Lynch 2014 Health Care Conference
May 14, 2014 (Wednesday) – Las Vegas
10:00 a.m. Pacific time
- UBS Global Healthcare Conference
May 20, 2014 (Tuesday)
11:30 a.m. Eastern time
- Sanford C. Bernstein's 30th Annual Strategic Decisions Conference
May 29, 2014 (Thursday) – New York
8:00 a.m. Eastern time
The presentations will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's website at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. Any accompanying slides will be available on the Hospira website. A replay of the webcast will be available on the Hospira website approximately 24 hours after the live presentation for 30 days after the event.
Hospira, Inc., is the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 17,000 employees. Learn more at www.hospira.com.
SOURCE Hospira, Inc.